Novel immunotherapy in metastatic renal cell carcinoma.UroTodayDespite the rapid development of therapeutic modalities for metastatic renal cell carcinoma (mRCC) over the past decade to include a number of targeted antiangiogenic therapies and traditio… Continue reading
|
Stand Up To Cancer, St. Baldrick’s Foundation hail green light for CAR T cell therapy
EurekAlert (press release) “SU2C and the St. Baldrick’s Foundation have committed millions of dollars to the development of the chimeric antigen receptor (CAR) T cell therapy,” said Sung Poblete, PhD, RN, president and CEO of SU2C. “The Dream Team has especially investigated … |
|
Stand Up To Cancer, St. Baldrick’s Foundation hail green light for CAR T cell therapy
EurekAlert (press release) “SU2C and the St. Baldrick’s Foundation have committed millions of dollars to the development of the chimeric antigen receptor (CAR) T cell therapy,” said Sung Poblete, PhD, RN, president and CEO of SU2C. “The Dream Team has especially investigated … |
CBS New York |
FDA Panel Approves Immunotherapy Program To Fight Cancer
CBS New York “Now, in addition to chemo, radiation and surgery, this is the fourth thing – immunotherapy,” he said. In the lab, the patient’s own immune T-cells are genetically modified by a virus to recognize the patient’s cancer. Then, those custom-made white … |
|
Stand Up To Cancer, St. Baldrick’s Foundation hail green light for CAR T cell therapy
EurekAlert (press release) “SU2C and the St. Baldrick’s Foundation have committed millions of dollars to the development of the chimeric antigen receptor (CAR) T cell therapy,” said Sung Poblete, PhD, RN, president and CEO of SU2C. “The Dream Team has especially investigated … |
|
Stand Up To Cancer, St. Baldrick’s Foundation hail green light for CAR T cell therapy
EurekAlert (press release) “SU2C and the St. Baldrick’s Foundation have committed millions of dollars to the development of the chimeric antigen receptor (CAR) T cell therapy,” said Sung Poblete, PhD, RN, president and CEO of SU2C. “The Dream Team has especially investigated … |
|
Critics of Stem–Cell Research Are Not Anti-Science
The Chronicle of Higher Education (blog) (The Chronicle, July 10), Professor David Hopkins contributes in a small way to the political polarization of academic subjects when he treats “The conservative critique of . . . the hard sciences” as focused on “subjects like stem–cell research … |
|
Novartis CAR–T Therapy Drug Recommended by FDA Panel
Zacks.com CAR-T is manufactured for each individual patient using their own cells thereby making it different from typical small molecule or biologic therapies. During the treatment process, T cells are drawn from a patient’s blood. These cells are then … |